Advisor Partners LLC Vertex Pharmaceuticals Inc Transaction History

Advisor Partners LLC

$1.42 Billion
Q2 2022

A detailed history of Advisor Partners LLC transactions in Vertex Pharmaceuticals Inc stock. As of the latest transaction made, Advisor Partners LLC holds 10,133 shares of VRTX stock, worth $4.16 Million. This represents 0.2% of its overall portfolio holdings.

Number of Shares

10,133

Previous 8,730 16.07%

Holding current value

$4.16 Million

Previous $2.28 Million 25.33%

% of portfolio

0.2%

Previous 0.14%

20 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 11, 2022	BUY	$234.96 - $292.55 $329,648 - $410,447	1,403 Added 16.07%	10,133 $2.86 Million
Q1 2022 Apr 27, 2022	BUY	$221.42 - $260.97 $592,962 - $698,877	2,678 Added 44.25%	8,730 $2.28 Million
Q4 2021 Feb 04, 2022	BUY	$177.01 - $223.45 $214,713 - $271,044	1,213 Added 25.07%	6,052 $1.33 Million
Q3 2021 Nov 15, 2021	SELL	$181.39 - $202.99 $117,903 - $131,943	-650 Reduced 11.84%	4,839 $878,000
Q2 2021 Aug 12, 2021	SELL	$187.49 - $221.1 $173,240 - $204,296	-924 Reduced 14.41%	5,489 $1.11 Million
Q1 2021 Jun 01, 2021	SELL	$207.02 - $241.31 $96,264 - $112,209	-465 Reduced 6.76%	6,413 $1.38 Million
Q4 2020 Feb 17, 2021	SELL	$207.01 - $276.09 $151,324 - $201,821	-731 Reduced 9.61%	6,878 $1.63 Million
Q3 2020 Nov 19, 2020	SELL	$255.65 - $303.1 $51,385 - $60,923	-201 Reduced 2.57%	7,609 $2.07 Million
Q2 2020 Aug 13, 2020	BUY	$225.48 - $295.8 $140,474 - $184,283	623 Added 8.67%	7,810 $2.27 Million
Q1 2020 May 15, 2020	BUY	$199.77 - $247.81 $242,720 - $301,089	1,215 Added 20.34%	7,187 $1.71 Million
Q4 2019 Jan 24, 2020	BUY	$166.71 - $223.91 $55,347 - $74,338	332 Added 5.89%	5,972 $1.4 Million
Q3 2019 Oct 16, 2019	BUY	$166.23 - $187.09 $37,401 - $42,095	225 Added 4.16%	5,640 $956,000
Q2 2019 Jul 26, 2019	SELL	$164.61 - $190.37 $74,074 - $85,666	-450 Reduced 7.67%	5,415 $993,000
Q1 2019 Apr 23, 2019	BUY	$163.73 - $194.7 $654 - $778	4 Added 0.07%	5,865 $1.08 Million
Q4 2018 Jan 29, 2019	BUY	$151.91 - $192.21 $120,768 - $152,806	795 Added 15.69%	5,861 $971,000
Q3 2018 Nov 06, 2018	SELL	$167.73 - $192.74 $2,348 - $2,698	-14 Reduced 0.28%	5,066 $976,000
Q2 2018 Jul 25, 2018	BUY	$145.72 - $169.96 $3,351 - $3,909	23 Added 0.45%	5,080 $863,000
Q1 2018 May 03, 2018	BUY	$151.6 - $177.13 $8,792 - $10,273	58 Added 1.16%	5,057 $824,000
Q4 2017 Jan 26, 2018	SELL	$137.28 - $155.55 $7,138 - $8,088	-52 Reduced 1.03%	4,999 $790,000
Q3 2017 Nov 03, 2017	BUY	$148.13 - $162.24 $748,204 - $819,474	5,051	5,051 $768,000

Others Institutions Holding VRTX

# of Institutions

1,724

Shares Held

221M

Call Options Held

1.58M

Put Options Held

1.36M

View Full List

About VERTEX PHARMACEUTICALS INC

Ticker VRTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 256,691,008
Market Cap $105B
Description
Vertex Pharmaceuticals Incorporated, a biotechnology company, engages in developing and commercializing therapies for treating cystic fibrosis. The company markets SYMDEKO/SYMKEVI, ORKAMBI, and KALYDECO to treat patients with cystic fibrosis who have specific mutations in their cystic fibrosis transmembrane conductance regulator gene; and TRIKAF...

More about VRTX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Advisor Partners LLC, based on Form 13F filings with the SEC.

News

Stay updated on Advisor Partners LLC with notifications on news.

Account

Advisor Partners LLC Vertex Pharmaceuticals Inc Transaction History